Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

The Journal of allergy and clinical immunology
2007
https://researcherprofiles.org/profile/1453856
17418382
Pahwa S, Muresan P, Sleasman J, Fenton T, Moye J, Deveikis A, Wara D, Van Dyke R, Pediatric Aids Clinical Trials Study 402 team